Urology of Indiana is a clinical research site located in Carmel, Indiana, United States 46032.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Urology of Indiana has participated in 8 clinical trials with 7 currently active.
Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-muscle Invasive Bladder Cancer, NMIBC.
Sponsors: Dendreon, ImmunityBio, Inc., Sumitomo Pharma America, Inc..
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Urology of Indiana has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Urology of Indiana has 8 clinical trials on record, with 7 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-muscle Invasive Bladder Cancer, NMIBC.
Yes — Urology of Indiana holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.